Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by CHARLES CLEELAND and TITO R MENDOZA.
CHARLES CLEELAND
Connection Strength
15.034
TITO R MENDOZA
  1. Developing a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma. Sci Rep. 2024 06 27; 14(1):14839.
    View in: PubMed
    Score: 0.972
  2. The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment. J Patient Rep Outcomes. 2020 Feb 19; 4(1):15.
    View in: PubMed
    Score: 0.719
  3. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). J Patient Rep Outcomes. 2019 Jun 17; 3(1):34.
    View in: PubMed
    Score: 0.686
  4. The contribution of pain in determining the health status of cancer patients with bone metastases: A secondary analysis of data from three Phase III registration trials. Eur J Pain. 2018 03; 22(3):565-571.
    View in: PubMed
    Score: 0.613
  5. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale. J Pain. 2015 Oct; 16(10):1032-43.
    View in: PubMed
    Score: 0.524
  6. Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain. 2012 Jun; 13(6):564-70.
    View in: PubMed
    Score: 0.419
  7. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist. 2011; 16(2):217-27.
    View in: PubMed
    Score: 0.384
  8. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
    View in: PubMed
    Score: 0.379
  9. Reliability and validity of a modified Brief Pain Inventory short form in patients with osteoarthritis. Eur J Pain. 2006 May; 10(4):353-61.
    View in: PubMed
    Score: 0.262
  10. The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain. 2004 Sep-Oct; 20(5):357-62.
    View in: PubMed
    Score: 0.246
  11. Lessons learned from a multiple-dose post-operative analgesic trial. Pain. 2004 May; 109(1-2):103-9.
    View in: PubMed
    Score: 0.241
  12. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
    View in: PubMed
    Score: 0.214
  13. Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Support Care Cancer. 2021 Oct; 29(10):6099-6107.
    View in: PubMed
    Score: 0.194
  14. Development and Validation of a Patient-reported Outcome Measure for Gastrointestinal Obstruction in the Setting of Advanced Malignancy. Ann Surg. 2022 12 01; 276(6):e805-e811.
    View in: PubMed
    Score: 0.191
  15. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.188
  16. Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints. Med Care. 2019 05; 57 Suppl 5 Suppl 1:S8-S12.
    View in: PubMed
    Score: 0.170
  17. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
    View in: PubMed
    Score: 0.170
  18. Assessment of baseline symptom burden in treatment-na?ve patients with lung cancer: an observational study. Support Care Cancer. 2019 Sep; 27(9):3439-3447.
    View in: PubMed
    Score: 0.167
  19. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM). Qual Life Res. 2018 Dec; 27(12):3229-3241.
    View in: PubMed
    Score: 0.163
  20. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028.
    View in: PubMed
    Score: 0.162
  21. Determination of mild, moderate, and severe pain interference in patients with cancer. Pain. 2017 06; 158(6):1108-1112.
    View in: PubMed
    Score: 0.149
  22. Validation of the Persian Version of the Brief Pain Inventory (BPI-P) in Chronic Pain Patients. J Pain Symptom Manage. 2017 07; 54(1):132-138.e2.
    View in: PubMed
    Score: 0.148
  23. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
    View in: PubMed
    Score: 0.147
  24. Validity and reliability of a Turkish Brief Pain Inventory Short Form when used to evaluate musculoskeletal pain. J Back Musculoskelet Rehabil. 2017; 30(2):229-233.
    View in: PubMed
    Score: 0.145
  25. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751.
    View in: PubMed
    Score: 0.142
  26. Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. Eur J Cancer. 2016 11; 67:83-90.
    View in: PubMed
    Score: 0.142
  27. Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer. Oncology. 2016; 90(3):127-35.
    View in: PubMed
    Score: 0.136
  28. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language. J Pain Symptom Manage. 2016 06; 51(6):1055-61.
    View in: PubMed
    Score: 0.136
  29. Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis. Cancer. 2015 Apr 01; 121(7):1138-46.
    View in: PubMed
    Score: 0.125
  30. The symptom burden of treatment-naive patients with head and neck cancer. Cancer. 2015 Mar 01; 121(5):766-73.
    View in: PubMed
    Score: 0.125
  31. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32.
    View in: PubMed
    Score: 0.118
  32. Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res. 2014 Mar 01; 20(5):1366-74.
    View in: PubMed
    Score: 0.118
  33. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group. Clin Genitourin Cancer. 2014 Feb; 12(1):41-9.
    View in: PubMed
    Score: 0.116
  34. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40.
    View in: PubMed
    Score: 0.115
  35. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer. 2013 Oct; 13(5):325-34.
    View in: PubMed
    Score: 0.113
  36. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol. 2013 Aug; 130(2):323-8.
    View in: PubMed
    Score: 0.112
  37. Authors' reply to Tendas et al. J Pain Symptom Manage. 2013 Apr; 45(4):e3-4.
    View in: PubMed
    Score: 0.112
  38. Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy. Qual Life Res. 2013 Nov; 22(9):2331-9.
    View in: PubMed
    Score: 0.111
  39. Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol. 2013 Feb 05; 6:13.
    View in: PubMed
    Score: 0.110
  40. Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer. Qual Life Res. 2013 Oct; 22(8):2143-50.
    View in: PubMed
    Score: 0.110
  41. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012 Aug; 44(2):168-80.
    View in: PubMed
    Score: 0.106
  42. Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol. 2012 Jun 01; 30(16):1980-8.
    View in: PubMed
    Score: 0.104
  43. Congruence of primary brain tumor patient and caregiver symptom report. Cancer. 2012 Oct 15; 118(20):5026-37.
    View in: PubMed
    Score: 0.104
  44. Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer center. J Clin Oncol. 2011 Jul 20; 29(21):2859-65.
    View in: PubMed
    Score: 0.099
  45. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.
    View in: PubMed
    Score: 0.096
  46. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients. Cancer. 2011 Jul 15; 117(14):3222-8.
    View in: PubMed
    Score: 0.096
  47. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9.
    View in: PubMed
    Score: 0.094
  48. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9.
    View in: PubMed
    Score: 0.092
  49. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI). Cancer. 2010 Apr 15; 116(8):2053-63.
    View in: PubMed
    Score: 0.091
  50. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine. 2010 Apr; 12(4):421-30.
    View in: PubMed
    Score: 0.091
  51. Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer. 2010 Jan 01; 116(1):137-45.
    View in: PubMed
    Score: 0.089
  52. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory. Oncology. 2009; 76(1):59-68.
    View in: PubMed
    Score: 0.083
  53. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.081
  54. Clinical utility of the MDASI-BT in patients with brain metastases. J Pain Symptom Manage. 2009 Mar; 37(3):331-40.
    View in: PubMed
    Score: 0.081
  55. The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
    View in: PubMed
    Score: 0.080
  56. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008 Oct; 36(4):367-73.
    View in: PubMed
    Score: 0.079
  57. Fatigue in the general Korean population: application and normative data of the Brief Fatigue Inventory. J Pain Symptom Manage. 2008 Sep; 36(3):259-67.
    View in: PubMed
    Score: 0.079
  58. Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Palliat Care Pharmacother. 2008; 22(1):7-20.
    View in: PubMed
    Score: 0.078
  59. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
    View in: PubMed
    Score: 0.076
  60. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(12):759-66.
    View in: PubMed
    Score: 0.074
  61. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76.
    View in: PubMed
    Score: 0.073
  62. An urban community's preferences for hypothetical outcomes of analgesic pain treatment. J Pain Symptom Manage. 2006 Nov; 32(5):470-7.
    View in: PubMed
    Score: 0.072
  63. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
    View in: PubMed
    Score: 0.070
  64. Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006 Jul 01; 107(1):207-14.
    View in: PubMed
    Score: 0.070
  65. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52.
    View in: PubMed
    Score: 0.069
  66. Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol. 2006 Oct; 80(1):27-35.
    View in: PubMed
    Score: 0.069
  67. Asking the community about cutpoints used to describe mild, moderate, and severe pain. J Pain. 2006 Jan; 7(1):49-56.
    View in: PubMed
    Score: 0.068
  68. Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol. 2005 Jun; 16(6):972-80.
    View in: PubMed
    Score: 0.064
  69. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72.
    View in: PubMed
    Score: 0.063
  70. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25.
    View in: PubMed
    Score: 0.063
  71. Perceptions of analgesic use and side effects: what the public values in pain management. J Pain Symptom Manage. 2004 Nov; 28(5):460-73.
    View in: PubMed
    Score: 0.062
  72. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
    View in: PubMed
    Score: 0.062
  73. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004 Sep-Oct; 20(5):309-18.
    View in: PubMed
    Score: 0.062
  74. The analgesic effects that underlie patient satisfaction with treatment. Pain. 2004 Jul; 110(1-2):480-7.
    View in: PubMed
    Score: 0.061
  75. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
    View in: PubMed
    Score: 0.060
  76. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44.
    View in: PubMed
    Score: 0.059
  77. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10.
    View in: PubMed
    Score: 0.059
  78. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain? J Natl Compr Canc Netw. 2023 11; 21(11):1132-1140.e3.
    View in: PubMed
    Score: 0.058
  79. Pain and fatigue in community-dwelling adults. Pain Med. 2003 Sep; 4(3):231-7.
    View in: PubMed
    Score: 0.057
  80. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59.
    View in: PubMed
    Score: 0.057
  81. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes. 2023 05 26; 7(1):48.
    View in: PubMed
    Score: 0.056
  82. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage. 2003 May; 25(5):449-58.
    View in: PubMed
    Score: 0.056
  83. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18.
    View in: PubMed
    Score: 0.056
  84. Development and validation of a patient-reported outcome measure to assess symptom burden after chimeric antigen receptor T-cell therapy. Br J Haematol. 2023 05; 201(4):738-746.
    View in: PubMed
    Score: 0.055
  85. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002 Apr 15; 94(8):2295-304.
    View in: PubMed
    Score: 0.052
  86. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. J Clin Oncol. 2002 Mar 01; 20(5):1319-28.
    View in: PubMed
    Score: 0.052
  87. Effects of patient-reported outcome assessment order. Clin Trials. 2022 06; 19(3):307-315.
    View in: PubMed
    Score: 0.051
  88. Identification of Breast Cancer Survivors With High Symptom Burden. Cancer Nurs. 2022 Jul-Aug 01; 45(4):253-261.
    View in: PubMed
    Score: 0.051
  89. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer. 2001 Sep 15; 92(6 Suppl):1708-13.
    View in: PubMed
    Score: 0.050
  90. Fatigue during preoperative chemoradiation for resectable rectal cancer. Cancer. 2001 Sep 15; 92(6 Suppl):1725-32.
    View in: PubMed
    Score: 0.050
  91. A preliminary study of the utility of the brief hospice inventory. J Pain Symptom Manage. 2001 Aug; 22(2):637-48.
    View in: PubMed
    Score: 0.050
  92. Greek brief pain inventory: validation and utility in cancer pain. Oncology. 2001; 60(1):35-42.
    View in: PubMed
    Score: 0.048
  93. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021 02; 18(1):104-114.
    View in: PubMed
    Score: 0.047
  94. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module. Neurooncol Pract. 2021 Apr; 8(2):137-147.
    View in: PubMed
    Score: 0.047
  95. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer. 2000 Oct 01; 89(7):1634-46.
    View in: PubMed
    Score: 0.047
  96. Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module. Jpn J Clin Oncol. 2020 Jul 09; 50(7):787-793.
    View in: PubMed
    Score: 0.046
  97. What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer. JCO Oncol Pract. 2020 10; 16(10):e1151-e1160.
    View in: PubMed
    Score: 0.046
  98. Minority cancer patients and their providers: pain management attitudes and practice. Cancer. 2000 Apr 15; 88(8):1929-38.
    View in: PubMed
    Score: 0.045
  99. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer. J Pain Symptom Manage. 2020 05; 59(5):1052-1058.e1.
    View in: PubMed
    Score: 0.045
  100. Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 08; 38(4):1166-1174.
    View in: PubMed
    Score: 0.044
  101. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790.
    View in: PubMed
    Score: 0.044
  102. Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial. Int J Radiat Oncol Biol Phys. 2020 01 01; 106(1):100-107.
    View in: PubMed
    Score: 0.044
  103. Patient-reported outcomes in light of supportive medications in treatment-na?ve lung cancer patients. Support Care Cancer. 2020 Apr; 28(4):1809-1816.
    View in: PubMed
    Score: 0.043
  104. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999 Mar 01; 85(5):1186-96.
    View in: PubMed
    Score: 0.042
  105. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory--BPI-H. J Pain Symptom Manage. 1999 Jan; 17(1):27-41.
    View in: PubMed
    Score: 0.042
  106. Software for Administering the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events: Usability Study. JMIR Hum Factors. 2018 Jul 16; 5(3):e10070.
    View in: PubMed
    Score: 0.040
  107. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 11 23; 12(1):186.
    View in: PubMed
    Score: 0.038
  108. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.038
  109. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain. 1996 Oct; 67(2-3):267-73.
    View in: PubMed
    Score: 0.036
  110. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996 Oct; 67(2-3):407-16.
    View in: PubMed
    Score: 0.036
  111. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 2016 Nov 15; 122(21):3401-3409.
    View in: PubMed
    Score: 0.035
  112. Linguistic Validation of the Turkish Version of the M.D. Anderson Symptom Inventory - Head and Neck Cancer Module. Balkan Med J. 2016 May; 33(3):339-43.
    View in: PubMed
    Score: 0.035
  113. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92.
    View in: PubMed
    Score: 0.034
  114. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys. 2016 07 15; 95(4):1107-14.
    View in: PubMed
    Score: 0.034
  115. Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016 Feb 12; 6:e396.
    View in: PubMed
    Score: 0.034
  116. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
    View in: PubMed
    Score: 0.033
  117. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol. 2015 Oct; 117(1):132-8.
    View in: PubMed
    Score: 0.033
  118. Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis. Biol Blood Marrow Transplant. 2016 Feb; 22(2):226-231.
    View in: PubMed
    Score: 0.033
  119. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-284.
    View in: PubMed
    Score: 0.032
  120. Automated pain intervention for underserved minority women with breast cancer. Cancer. 2015 Jun 01; 121(11):1882-90.
    View in: PubMed
    Score: 0.032
  121. Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leuk Lymphoma. 2015 May; 56(5):1335-41.
    View in: PubMed
    Score: 0.031
  122. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.031
  123. Nomogram for predicting symptom severity during radiation therapy for head and neck cancer. Otolaryngol Head Neck Surg. 2014 Oct; 151(4):619-26.
    View in: PubMed
    Score: 0.031
  124. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014 Jul 01; 120(13):1975-84.
    View in: PubMed
    Score: 0.030
  125. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14.
    View in: PubMed
    Score: 0.029
  126. Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood. 2013 Aug 01; 122(5):641-7.
    View in: PubMed
    Score: 0.028
  127. Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy. Cancer Chemother Pharmacol. 2013 Jun; 71(6):1531-40.
    View in: PubMed
    Score: 0.028
  128. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study. Head Neck. 2013 Oct; 35(10):1490-8.
    View in: PubMed
    Score: 0.027
  129. Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module. Forum Clin Oncol. 2012 Mar; 3(1):29-31.
    View in: PubMed
    Score: 0.026
  130. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):587-99.
    View in: PubMed
    Score: 0.025
  131. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011 Mar; 41(3):558-65.
    View in: PubMed
    Score: 0.024
  132. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9.
    View in: PubMed
    Score: 0.024
  133. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86.
    View in: PubMed
    Score: 0.023
  134. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.023
  135. The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations. Pain Med. 2010 Mar; 11(3):337-46.
    View in: PubMed
    Score: 0.022
  136. Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):775-81.
    View in: PubMed
    Score: 0.021
  137. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail. 2008 Aug; 14(6):497-507.
    View in: PubMed
    Score: 0.020
  138. Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage. 2008 Jan; 35(1):95-102.
    View in: PubMed
    Score: 0.019
  139. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6.
    View in: PubMed
    Score: 0.019
  140. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8.
    View in: PubMed
    Score: 0.018
  141. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
    View in: PubMed
    Score: 0.017
  142. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52.
    View in: PubMed
    Score: 0.017
  143. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53.
    View in: PubMed
    Score: 0.017
  144. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
    View in: PubMed
    Score: 0.015
  145. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004 Feb 07; 25(3):94-102.
    View in: PubMed
    Score: 0.015
  146. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42.
    View in: PubMed
    Score: 0.015
  147. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104.
    View in: PubMed
    Score: 0.015
  148. Validation study of the Japanese version of the brief fatigue inventory. J Pain Symptom Manage. 2003 Feb; 25(2):106-17.
    View in: PubMed
    Score: 0.014
  149. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002 Nov; 24(5):517-25.
    View in: PubMed
    Score: 0.014
  150. The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer. 1999 Nov 01; 86(9):1848-55.
    View in: PubMed
    Score: 0.011
  151. A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory--BPI-J. J Pain Symptom Manage. 1998 Dec; 16(6):364-73.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.